Skip to main navigation
Main Menu
About
Overview
Amgen History
Mission and Values
Leadership
Awards and Accolades
How We Operate
Overview
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Research and Development Strategy
Pipeline
Scientific Advisory Boards
Amgen Science
Amgen Competitive Grants
Biosimilars
Clinical Trials
Overview
About Clinical Trails
Amgen Clinical Trails
Clinical Study Report Synopses
Clinical Trial Diversity
Lay Summary of Clinical Trail Result
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support program
Investigator Sponsored Studies
Scientific Community Initiatives
Overview
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
Overview
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Counterfeit Drug Statement
Safety Data Sheets
Global Patient Safety
Overview
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
2019 Responsibility Highlights Report
Corporate Responsibility
Strategy & Governance
Overview
Amgen’s Commitment to Patients
Our Approach to Pricing,
Access and Affordability
Overview
Access to Medicine
Diversity, Inclusion and Belonging
Amgen Foundation
Overview
Programs for Students
Programs for Teachers
About the Amgen Foundation
Commitment to Community
Overview
Amgen Foundation Grants
Independent Medical Education Funding
Non-Healthcare Donations and Sponsorships
U.S. Healthcare Donations
Equipment Donations
Donation and Grant Recipients
Staff Engagement
Environment
Overview
Performance
2020 Plan
Sustainable by Design
Case Studies
Responsible Sourcing
Workplace
Reporting and Metrics
Overview
Archived Reports
Summary of Data
CDP
Stakeholder Engagement
Stories
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
Newsroom
Partners
Investors
Careers
Amgen Worldwide
Overview
Research and Development Strategy
Overview <i class="fa fa-external-link"></i>
Scientific Advisory Boards
Pipeline <i class="fa fa-external-link"></i>
Amgen Competitive Grants <i class="fa fa-external-link"></i>
Clinical Trials
Scientific Community Initiatives
Manufacturing
Overview
About Clinical Trails
Amgen Clinical Trails<i class="fa fa-external-link"></i>
Clinical Study Report Synopses<i class="fa fa-external-link"></i>
Clinical Trial Diversity
Lay Summary of Clinical Trail Result<i class="fa fa-external-link"></i>
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support program
Investigator Sponsored Studies<i class="fa fa-external-link"></i>
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
About
Overview
Amgen History
Mission and Values
Leadership
Awards and Accolades
How We Operate
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Research and Development Strategy
Pipeline
Scientific Advisory Boards
Amgen Science
Amgen Competitive Grants
Biosimilars
Clinical Trials
About Clinical Trials
Amgen Clinical Trials
Clinical Trial Diversity and Representation
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support Program
Investigator Sponsored Studies
Scientific Community Initiatives
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Counterfeit Drug Statement
Safety Data Sheets
Global Patient Safety
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
2019 Responsibility Highlights Report
Corporate Responsibility Strategy & Governance
Amgen's Commitment to Patients
Our Approach to Pricing, Access and Affordability
Access Approaches, Treatments, and Collaborations
Transformative Treatments, Approaches and Technology
Shaping the Future of Healthcare
Access to Medicine
U.S. Reimbursement Support Services and Financial Assistance Programs
Access to Medicines Initiatives Outside the U.S.
Access to Investigational Medicines
Amgen Foundation
Amgen Inspires
About the Amgen Foundation
Programs for Teachers
Programs for Students
Amgen Foundation Grants
Commitment to Community
Staff Engagement Programs
Independent Medical Education Funding
U.S. Healthcare Donations
Non-Healthcare Donations and Sponsorships
Equipment Donations
Donation and Grant Recipients List
Diversity, Inclusion & Belonging
Amgen's Commitment to Diversity, Inclusion and Belonging
Environment
Performance
2027 Plan
Sustainable by Design
Case Studies
Responsible Sourcing
Supplier Diversity
Supplier Sustainability
Workplace
Safety
Wellness
Reporting and Metrics
Summary of Data
CDP
Stakeholder Engagement
Archived Reports
Stories
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
Newsroom
Partners
Investors
Careers
X
Breadcrumb
Home
Investors
Reconciliations
Reconciliations
IR Menu
Investors
About
Leadership
Mission and Values
Quarterly Newsletter
News & Events
Press Releases
Presentations
Events Calendar
Annual Meeting
Financials
SEC Filings
Quarterly Earnings
Annual Reports
Tax Forms
Reconciliations
Pipeline
Stock
Stock Information
Dividend Information
Fundamentals
ESG
Corporate Governance
Responsibility
Environment
Diversity, Inclusion & Belonging
ESG FAQs
Resources
FAQs
Email Alerts
Request Information
Investor Contacts
09.18.2020
Form 8937
293.7 KB
05.19.2020
Q4 2019 Financial Results
212.4 KB
Navbar w/ text
Investors
About
Leadership
Mission and Values
Quarterly Newsletter
News & Events
Press Releases
Presentations
Events Calendar
Annual Meeting
Financials
SEC Filings
Quarterly Earnings
Annual Reports
Tax Forms
Reconciliations
Pipeline
Stock
Stock Information
Dividend Information
Fundamentals
ESG
Corporate Governance
Responsibility
Environment
Diversity, Inclusion & Belonging
ESG FAQs
Resources
FAQs
Email Alerts
Request Information
Investor Contacts
Earnings
Show all
Q4 2020
Q4 2020 Amgen Earnings Conference Call
Q4 2020 Amgen Earnings Conference Call Presentation
1.7 MB
Amgen Reports Fourth Quarter And Full Year 2020 Financial Results
ALL RESULTS
Data as of:
Data Provided by Refinitiv. Minimum 15 minutes delayed.
MORE STOCK
